Delivery Order SPE2DB25D3002-SPE2DB25FLPZF

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,757.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product, with an ultimate completion date of January 17, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,289.35 firm-fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,193.34 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product. The contract has an ultimate completion date of February 18, 2025 and was awarded on February 14, 2025. This appears to be a transaction under AmerisourceBergen's larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,740.30 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product used in the treatment of diabetes. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. This delivery order is part of a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,195.96 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of September 17, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,236.75 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,246.22 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product. The contract has an ultimate completion date of January 8, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,622.83 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has a completion date of February 20, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,225.44 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of December 7, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,818.54, is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
  • SPE2DB25D3002
    Indefinite Delivery Contract
  • SPE2DB25D3002-SPE2DB25FLPZF
    Delivery Order

This federal contract award, with the ID SPE2DB25D3002|SPE2DB25FLPZF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,150.32 firm fixed-price contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product, with a completion date of January 31, 2025.

The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. There is no set-aside designation for this award.

Generated 5/21/25, 9:59 AM